252.50
-0.39%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Stille
Its shares trade on Nasdaq Stockholm under the ticker STIL.ST. It has been listed since 29 August 1997. In the fiscal year to 31 December 2025, it reported revenue of SEK 567.6m and net income of SEK 55.7m. At that date it held total assets of SEK 1.05bn and shareholders' equity of SEK 708.7m.
Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 29 Aug 1997
- Website
- stille.se ↗
Leadership
Pay as last reported
- Mr. Jon SigurdssonIndependent Chairman of the Board
- Mr. Ulrik BerthelsenChief Executive Officer
- Mr. Pontus LuningGlobal Business Manager STILLE Instruments
- Mr. Ralph TammDirector of Products & Development, imagiQ
- Mr. Per CarlssonDirector
- Ms. Sirpa MakipaaDirector, Employee RepresentativeSEK 65,000
- Ms. Yonna OlssonDirector
- Mr. Victor SteienDirector
- Jens ViebkeDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Stille AB develops handcrafted surgical instruments for cardiovascular surgery and plastic surgery.
- Stille AB manufactures specialized tables for cardiovascular surgery and gynecology procedures.
- Stille AB has two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB.
Weaknesses
- Stille AB's largest shareholder is Linc Invest AB with 39.81% ownership.
- Stille AB sold its Sonesta business unit to ADDvise Lab Solutions publ AB on September 2, 2013.
- Stille AB's headquarters is in Torshaella, Sodermanlands, Sweden.
Opportunities
- Stille AB operates in the Health Care sector with a focus on medical equipment development.
- Stille AB's product portfolio includes scissors, forceps, and needle holders for surgical use.
- Stille AB's business lines serve cardiovascular surgery and reconstructive plastic surgery markets.
Threats
- Stille AB's business unit Sonesta was sold to ADDvise Lab Solutions publ AB in 2013.
- Stille AB's headquarters location in Torshaella, Sweden, may limit market expansion.
- Stille AB's largest shareholder Linc Invest AB holds 39.81% of shares, creating potential influence.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.